Greenwood Capital Associates’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-5,655
| Closed | -$551K | – | 213 |
|
|
2018
Q4 | $551K | Buy |
5,655
+1,180
| +26% | +$115K | 0.14% | 90 |
|
|
2018
Q3 | $622K | Buy |
+4,475
| New | +$622K | 0.14% | 91 |
|
|
2017
Q1 | – | Sell |
-1,653
| Closed | -$202K | – | 224 |
|
|
2016
Q4 | $202K | Buy |
+1,653
| New | +$202K | 0.06% | 177 |
|
|
2014
Q2 | – | Sell |
-14,530
| Closed | -$2.21M | – | 158 |
|
|
2014
Q1 | $2.21M | Sell |
14,530
-17,325
| -54% | -$2.64M | 0.71% | 68 |
|
|
2013
Q4 | $4.23M | Buy |
31,855
+11,884
| +60% | +$1.58M | 1.31% | 25 |
|
|
2013
Q3 | $2.32M | Buy |
+19,971
| New | +$2.32M | 0.82% | 53 |
|